Fludeoxyglucose F 18 Injection, Solution
Product Images NDC 76318-334

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 76318-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Massachusetts General Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (Fdg Vial Label)

The text describes a medical product called FLUDEOXYGLUCOSE F18 INJECTION with a concentration of 20 mCi/mL to 300 mC/mL. The product is produced by Massachusetts General Hospital PET Center and each lot is identified by MGH-LB-04 No. 0-0001. The product is radioactive and the label contains a cautionary statement advising not to use it if cloudy or contains particulate matter.*

FDA Label Image

Chemical Structure (Fdg)

FDA Label Image

Lead Shield Label (Fdgsafelabel)

Fludeoxvalucose F-18 Injection is a diagnostic intravenous solution that should be stored in a shielded container at 25°C and expires 12 hours after batch number GB4's insert. It is non-pyrogenic, sterile, and should be withdrawn aseptically before handling doses. Its activity and concentration can be calculated from the calibration (EOS) date and time; and the dosage should be determined accordingly. The manufactured by Massachusetts General Hospital PET Center located at 55 Fruit Street, Boston, MA 02114.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.